NanoGroup S.A.
NNG | WAR
Overview
Corporate Details
- ISIN(s):
- PLNNGRP00011 (+3 more)
- LEI:
- 259400HXWEAZUWRLY648
- Country:
- Poland
- Address:
- Warszawa Rakowiecka 36, 02-532 Warszawa
- Website:
- https://en.nanogroup.eu/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Mission of NanoGroup is to build a cluster of medical and biotechnological companies active in the field of diagnostics, therapy and rehabilitation of oncological patients. Currently, the group is managing five technologically advanced nanoengineering projects organized under three specialized startups. NanoGroup plans to sell licenses to its early-stage solutions (pre-clinical and clinical phase 1st) to international biotech companies and pharmaceutical companies.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-27 13:24 |
Declaration of Voting Results & Voting Rights Announcements
Lista Akcjonariuszy
|
Polish | 49.9 KB | |
| 2025-06-27 13:24 |
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Wa…
|
Polish | 372 bytes | |
| 2025-06-27 13:17 |
Declaration of Voting Results & Voting Rights Announcements
Uchwały_ZWZ 27.06.2025
|
Polish | 112.8 KB | |
| 2025-06-27 13:17 |
Declaration of Voting Results & Voting Rights Announcements
Treść uchwał podjętych podczas obrad Zwyczajnego Walnego Zgromadzenia NanoGroup…
|
Polish | 997 bytes | |
| 2025-06-26 09:38 |
Corporate Governance Report
Sprawozdanie Rady Nadzorczej za rok 2024
|
Polish | 1.1 MB | |
| 2025-06-26 09:38 |
Report Publication Announcement
Treść dokumentów, które mają być przedmiotem obrad Zwyczajnego Walnego Zgromadz…
|
Polish | 1.2 KB | |
| 2025-06-23 15:05 |
Inside Information Statement
Nabycie spółki DOTO MEDICAL sp. z o.o. oraz platformy aptamerowej - Content (PL)
|
Polish | 3.2 KB | |
| 2025-06-18 21:14 |
Directors' Dealings
T.Wesołowski
|
Polish | 4.4 KB | |
| 2025-06-18 21:14 |
Directors' Dealings
Powiadomienie o transakcjach, o których mowa w art. 19 ust. 1 rozporządzenia MA…
|
Polish | 569 bytes | |
| 2025-06-18 21:09 |
Directors' Dealings
Mar 19
|
Polish | 4.4 KB | |
| 2025-06-18 21:09 |
Directors' Dealings
Powiadomienie o transakcjach, o których mowa w art. 19 ust. 1 rozporządzenia MA…
|
Polish | 605 bytes | |
| 2025-06-13 17:25 |
Directors' Dealings
powiadomienie
|
Polish | 5.2 KB | |
| 2025-06-13 17:25 |
Directors' Dealings
Powiadomienie o transakcjach, o którym mowa w art. 19 ust. 1 rozporządzenia MAR…
|
Polish | 440 bytes | |
| 2025-06-12 17:32 |
Prospectus
Dokument dopuszczenia akcji
|
Polish | 716.8 KB | |
| 2025-06-12 17:32 |
Regulatory News Service
Korekta dokumentu związanego z dopuszczeniem do obrotu na rynku regulowanym pro…
|
Polish | 3.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |